PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
Recruiting now
Conditions studied: PANS, PANDAS
In brief
The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects in a study to determine the incidence and natural history of children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) with regard to spectrum, course and outcome. The investigators aim to demonstrate they can recruit and retain 85% of children who are eligible for this study. Eligible children are those who fit criteria for PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS). Each child will be followed for one year.
Key facts
- Study ID
- NCT06811935
- Run by
- University of Wisconsin, Madison
- People needed
- 30
- Starts
- 2025-02-17
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-01-27
Who can join
Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States (enrolling)
- UW School of Medicine and Public Health — Madison, Wisconsin, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.